Lupin Must Halt Sales of Generic Diabetes Drug: Judge

A federal judge on Tuesday ordered Lupin Ltd. to stop selling its generic version of Type 2 diabetes treatment Fortamet, the subject of a patent infringement suit, but denied patent holder Shionogi Pharma Inc.'s request to recall the generics already on the market.
Law360